Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 9:24 pm Sale | 2026-06-30 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Ikarian Capital, LLC | 4,338,534 6.900% | -594,552 (-12.05%) | Filing History |
| 2026-08-14 10:45 am Sale | 2026-06-30 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 2,520,359 4.000% | -1,355,677 (-34.98%) | Filing History |
| 2026-05-15 1:47 pm Sale | 2026-03-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 3,876,036 6.200% | -1,139,924 (-22.73%) | Filing History |
| 2026-04-14 11:14 am Unchanged | 2026-04-14 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | BioFortune Inc | 6,026,813 9.600% | 0 (Unchanged) | Filing History |
| 2026-04-01 4:30 pm Purchase | 2026-03-31 | 13D | CONNECT BIOPHARMA HOLDINGS LIM CNTB | Panacea Innovation Limited | 13,160,000 21.200% | 1,160,000 (+9.67%) | Filing History |
| 2026-02-17 9:20 pm Sale | 2025-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | BioFortune Inc | 6,026,813 10.800% | -701,479 (-10.43%) | Filing History |
| 2026-02-17 8:52 pm Sale | 2025-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 5,015,960 9.000% | -511,568 (-9.25%) | Filing History |
| 2026-02-17 5:22 pm Purchase | 2025-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Ikarian Capital, LLC | 4,933,086 8.800% | 4,933,086 (New Position) | Filing History |
| 2025-11-28 4:23 pm Sale | 2025-11-26 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 5,527,528 9.900% | -960,017 (-14.80%) | Filing History |
| 2025-11-26 4:30 pm Sale | 2025-11-24 | 13D | CONNECT BIOPHARMA HOLDINGS LIM CNTB | Panacea Innovation Limited | 12,000,000 21.500% | -1,950,000 (-13.98%) | Filing History |
| 2025-07-21 09:00 am Purchase | 2025-07-21 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 13,950,000 25.100% | 540,000 (+4.03%) | Filing History |
| 2024-07-01 4:16 pm Purchase | 2024-06-27 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 13,410,000 24.300% | 1,410,000 (+11.75%) | Filing History |
| 2024-02-27 9:00 pm Purchase | 2024-02-23 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 12,000,000 21.800% | 3,100,000 (+34.83%) | Filing History |
| 2024-02-27 4:19 pm Sale | 2024-02-23 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA Capital Management, L.P. | 0 0.000% | -3,062,871 (Position Closed) | Filing History |
| 2024-02-13 4:30 pm Purchase | 2024-02-12 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 8,900,000 16.200% | 8,900,000 (New Position) | Filing History |
| 2024-02-13 4:27 pm Purchase | 2023-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | BioFortune Inc | 6,728,292 12.100% | 511,767 (+8.23%) | Filing History |
| 2024-02-13 4:18 pm Purchase | 2023-12-31 | 13G | CONNECT BIOPHARMA HLDGS LTD CNTB | Wei Zheng | 6,487,545 11.700% | 262,198 (+4.21%) | Filing History |
| 2023-12-20 4:30 pm Sale | 2023-12-18 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA Capital Management, L.P. | 3,062,871 5.600% | -2,061,438 (-40.23%) | Filing History |
| 2023-12-14 4:30 pm Sale | 2023-12-12 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA Capital Management, L.P. | 5,124,309 9.300% | -830,702 (-13.95%) | Filing History |
| 2023-12-04 5:20 pm Sale | 2023-11-30 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | RA Capital Management, L.P. | 5,955,011 10.800% | -1,035,992 (-14.82%) | Filing History |